Abpro Holdings, Inc.·4/A

Nov 25, 9:58 PM ET

Suk Jin Wook (Miles) 4/A

4/A · Abpro Holdings, Inc. · Filed Nov 25, 2024

Insider Transaction Report

Form 4/AAmended
Period: 2024-11-13
Suk Jin Wook (Miles)
DirectorCEO and Chairman
Transactions
  • Award

    Stock option (right to buy)

    2024-11-13+613,500613,500 total(indirect: By Biocelsus International Co. Ltd.)
    Exercise: $1.63Exp: 2032-02-18Common Stock, par value $0.0001 per share (613,500 underlying)
Footnotes (4)
  • [F1]On November 15, 2024, the reporting person filed a Form 4 which inadvertently omitted the transaction disclosed hereby.
  • [F2]Reflects the issuance by Abpro Holdings, Inc. (f/k/a Atlantic Coastal Acquisition Corp. II) (the "Issuer") on November 13, 2024, of rollover stock option awards in connection with the business combination between the Issuer and Abpro Corporation, a Delaware corporation ("Abpro"), pursuant to a Business Combination Agreement, dated as of December 11, 2023 (as amended by Amendment No. 1 to Business Combination Agreement, dated September 4, 2024, the "Business Combination Agreement"), by and among the Issuer, Abpro Merger Sub Corp, a Delaware corporation, and Abpro.
  • [F3]This stock option award is 100% vested.
  • [F4]Biocelsus International Co. Ltd. is controlled by the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Documents

1 file
  • 4
    primary_doc.xml

    PRIMARY DOCUMENT